Drug recall D-0495-2021
Product
TIROSINT(levothyroxine sodium) capsules 175MCG 3 blisters X10 capsules; NDC/UPC 71858-0055-4; RX; CAPSULES
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
200606
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 25 boxes
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Tirosint – drug information
- NDC 71858-0055 Tirosint · Levothyroxine Sodium 175 ug/1 · IBSA Pharma Inc.
- NDC 71858-0050 Tirosint · Levothyroxine Sodium 150 ug/1 · IBSA Pharma Inc.
- NDC 71858-0005 Tirosint · Levothyroxine Sodium 13 ug/1 · IBSA Pharma Inc.
- NDC 71858-0060 Tirosint · Levothyroxine Sodium 200 ug/1 · IBSA Pharma Inc.
- NDC 71858-0017 Tirosint · Levothyroxine Sodium 62.5 ug/1 · IBSA Pharma Inc.
- NDC 71858-0015 Tirosint · Levothyroxine Sodium 50 ug/1 · IBSA Pharma Inc.
- NDC 71858-0012 Tirosint · Levothyroxine Sodium 37.5 ug/1 · IBSA Pharma Inc.
- NDC 71858-0025 Tirosint · Levothyroxine Sodium 88 ug/1 · IBSA Pharma Inc.
- NDC 71858-0030 Tirosint · Levothyroxine Sodium 100 ug/1 · IBSA Pharma Inc.
- NDC 71858-0045 Tirosint · Levothyroxine Sodium 137 ug/1 · IBSA Pharma Inc.
- NDC 71858-0020 Tirosint · Levothyroxine Sodium 75 ug/1 · IBSA Pharma Inc.
- NDC 71858-0010 Tirosint · Levothyroxine Sodium 25 ug/1 · IBSA Pharma Inc.
- NDC 71858-0035 Tirosint · Levothyroxine Sodium 112 ug/1 · IBSA Pharma Inc.
- NDC 71858-0013 Tirosint · Levothyroxine Sodium 44 ug/1 · IBSA Pharma Inc.
- NDC 71858-0040 Tirosint · Levothyroxine Sodium 125 ug/1 · IBSA Pharma Inc.